These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 5108387)

  • 21. Simultaneous administration of live virus vaccines. Measles, mumps, poliomyelitis, and smallpox.
    Karchmer AW; Friedman JP; Casey HL; Shope TC; Riker JB; Kappelman MM; Witte JJ
    Am J Dis Child; 1971 May; 121(5):382-8. PubMed ID: 4933290
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mumps-antibody formation in guinea pigs following a single virus application. Evaluation of live mumps-virus vaccine].
    Gladthe H; Abel C
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(2):202-7. PubMed ID: 5064723
    [No Abstract]   [Full Text] [Related]  

  • 23. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination vaccine.
    Arch Intern Med; 1970 Oct; 126(4):576. PubMed ID: 5506960
    [No Abstract]   [Full Text] [Related]  

  • 25. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.
    Hilleman MR; Buynak EB; Whitman JE; Weibel RW; Stokes J
    Am J Dis Child; 1969 Aug; 118(2):166-71. PubMed ID: 5815860
    [No Abstract]   [Full Text] [Related]  

  • 26. Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.
    Stokes J; Weibel RE; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
    JAMA; 1971 Oct; 218(1):57-61. PubMed ID: 4937795
    [No Abstract]   [Full Text] [Related]  

  • 27. Measurement of immunity following live mumps (5 years), measles (3 years), and rubella (2 and one-half years) virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1972 Mar; 49(3):334-41. PubMed ID: 5010464
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined vaccine against measles, mumps, rubella, and varicella.
    Brunell PA; Novelli VM; Lipton SV; Pollock B
    Pediatrics; 1988 Jun; 81(6):779-84. PubMed ID: 2835743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on live rubella vaccine. V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine.
    Minekawa Y; Ueda S; Yamanishi K; Ogino T; Takahashi M
    Biken J; 1974 Dec; 17(4):161-7. PubMed ID: 4464833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of rubella during an epidemic on Taiwan. HPV-77 and RA 27-3 rubella vaccines administered subcutaneously and intranasally HPV-77 vaccine mixed with mumps and-or measles vaccines.
    Beasley RP; Detels R; Kim KS; Gale JL; Lin TL; Grayston JT
    Am J Dis Child; 1969 Aug; 118(2):301-6. PubMed ID: 4893832
    [No Abstract]   [Full Text] [Related]  

  • 31. Exposure of susceptible pregnant women to rubella vaccinees. Serologic findings during the Rhode Island immunization campaign.
    Scott HD; Byrne EB
    JAMA; 1971 Jan; 215(4):609-12. PubMed ID: 5107437
    [No Abstract]   [Full Text] [Related]  

  • 32. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
    Krober MS; Stracener CE; Bass JW
    JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination of adults with Wistar RA 27/3 rubella vaccine.
    Freestone DS; Prydie J; Smith SG; Laurence G
    J Hyg (Lond); 1971 Sep; 69(3):471-7. PubMed ID: 5285946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined live measles-rubella virus vaccine. Findings in clinical laboratory studies.
    Villarejos VM; Arguedas JA; Buynak EB; Weibel RE; Stokes J; Hilleman MR
    J Pediatr; 1971 Oct; 79(4):599-604. PubMed ID: 5094254
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on live mumps virus vaccine. 3. Evaluation of newly developed live mumps virus vaccine.
    Yamanishi K; Takahashi M; Kurimura T; Ueda S; Minekawa Y
    Biken J; 1970 Sep; 13(3):157-61. PubMed ID: 4992054
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
    JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled family study of live, attenuated rubella-virus vaccine.
    Lefkowitz LB; Rafajko RR; Federspiel CF; Quinn RW
    N Engl J Med; 1970 Jul; 283(5):229-32. PubMed ID: 4912790
    [No Abstract]   [Full Text] [Related]  

  • 39. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM; Baker L; Starr SE; Plotkin SA
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on live mumps virus vaccine. IV. Clinical and serological follow-up 2 year and 3 years after vaccination.
    Yamanishi K; Takahashi M; Kurimura T; Ueda S; Suzuki N
    Biken J; 1971 Sep; 14(3):259-65. PubMed ID: 5156905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.